Dow Down 1.29% Nasdaq Down 3.25%

ChemoCentryx, Inc. (CCXI)

-NasdaqGS
3.60 Down 0.10(2.70%) Feb 5, 4:00PM EST
Prev Close:3.70
Open:3.67
Bid:3.60 x 9300
Ask:3.61 x 300
1y Target Est:13.00
Beta:1.86378
Earnings Date:Mar 10 - Mar 14 (Est.)
Day's Range:3.54 - 4.00
52wk Range:3.50 - 9.46
Volume:102,971
Avg Vol (3m):189,524
Market Cap:158.88M
P/E (ttm):N/A
EPS (ttm):-1.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CCXIDown 2.70%158.88M
ABTDown 1.58%55.81B
AZNDown 1.44%75.92B
AMGNDown 3.25%109.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.10
Quarterly EPS Est (Dec-15) :-0.28
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback